Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 18:36:28 GMT 2025
by
admin
on
Mon Mar 31 18:36:28 GMT 2025
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IGG1 |
| Sequence Origin | HUMAN |
| Sequence Type | COMPLETE |
| Record UNII |
V43X8G4797
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C20401
Created by
admin on Mon Mar 31 18:36:28 GMT 2025 , Edited by admin on Mon Mar 31 18:36:28 GMT 2025
|
||
|
FDA ORPHAN DRUG |
199104
Created by
admin on Mon Mar 31 18:36:28 GMT 2025 , Edited by admin on Mon Mar 31 18:36:28 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
8683
Created by
admin on Mon Mar 31 18:36:28 GMT 2025 , Edited by admin on Mon Mar 31 18:36:28 GMT 2025
|
PRIMARY | |||
|
STAMULUMAB
Created by
admin on Mon Mar 31 18:36:28 GMT 2025 , Edited by admin on Mon Mar 31 18:36:28 GMT 2025
|
PRIMARY | |||
|
C95795
Created by
admin on Mon Mar 31 18:36:28 GMT 2025 , Edited by admin on Mon Mar 31 18:36:28 GMT 2025
|
PRIMARY | |||
|
705287-60-1
Created by
admin on Mon Mar 31 18:36:28 GMT 2025 , Edited by admin on Mon Mar 31 18:36:28 GMT 2025
|
PRIMARY | |||
|
300000021843
Created by
admin on Mon Mar 31 18:36:28 GMT 2025 , Edited by admin on Mon Mar 31 18:36:28 GMT 2025
|
PRIMARY | |||
|
V43X8G4797
Created by
admin on Mon Mar 31 18:36:28 GMT 2025 , Edited by admin on Mon Mar 31 18:36:28 GMT 2025
|
PRIMARY | |||
|
DB05915
Created by
admin on Mon Mar 31 18:36:28 GMT 2025 , Edited by admin on Mon Mar 31 18:36:28 GMT 2025
|
PRIMARY | |||
|
CHEMBL2108051
Created by
admin on Mon Mar 31 18:36:28 GMT 2025 , Edited by admin on Mon Mar 31 18:36:28 GMT 2025
|
PRIMARY | |||
|
RR-13
Created by
admin on Mon Mar 31 18:36:28 GMT 2025 , Edited by admin on Mon Mar 31 18:36:28 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 1_144 | 1_200 |
| 1_220 | 4_210 |
| 1_226 | 2_226 |
| 1_229 | 2_229 |
| 1_261 | 1_321 |
| 1_367 | 1_425 |
| 2_22 | 2_96 |
| 2_144 | 2_200 |
| 1_220 | 4_210 |
| 2_261 | 2_321 |
| 2_367 | 2_425 |
| 3_22 | 3_87 |
| 3_133 | 3_192 |
| 4_22 | 4_87 |
| 4_133 | 4_192 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO ACID SUBSTITUION | [1_1] [2_1] | PIDOLIC ACID | SZB83O1W42 |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|